Regeneration in Movement Disorders
11 – 20 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [18F]flortaucipir imaging : TAU-SPEX
- Contribution to journal › Article
-
Mark
Comparison of two preprocessing methods for 18F-Flortaucipir PET quantification in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
STEM-PD trial protocol : a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease
- Contribution to journal › Article
-
Mark
Treatment-related amyloid clearance (TRAC) : a framework to characterize patients in the era of anti-amyloid therapies
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hemispheric Asymmetry of Amyloid Deposition Influences Asymmetric Tau Pathology in Alzheimer’s Disease
- Contribution to journal › Published meeting abstract
-
Mark
Longitudinal tau-PET accumulation and downstream effects in amyloid-beta negative cognitively unimpaired individuals
- Contribution to journal › Published meeting abstract
-
Mark
Frequency and Clinical Outcomes Associated with Tau Positron Emission Tomography Positivity
- Contribution to journal › Article
-
Mark
CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's disease
- Contribution to journal › Article
- 2024
-
Mark
Pericyte Microvesicles as Plasma Biomarkers Reflecting Brain Microvascular Signaling in Patients with Acute Ischemic Stroke
- Contribution to journal › Article
-
Mark
Plasma Biomarker Strategy for Selecting Patients with Alzheimer Disease for Antiamyloid Immunotherapies
- Contribution to journal › Article
